Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycosylation stabilizes TNFα and receptor complexes: structural and biophysical implications.

Carbohydrate research·2026
Same author

Comparison of Protein-Glycosaminoglycan Interactions in ff14sb/GLYCAM06j-1 and CHARMM36m Force Fields.

Journal of chemical information and modeling·2026
Same author

Acridinium Chemiluminogenic Labels-Synthesis, Analytical Performance, and Mechanism of Light Generation-A Comparison in View of Biomedical Diagnostics.

Molecules (Basel, Switzerland)·2026
Same author

Parametrization of β<sup>3</sup>-Peptides for Coarse-Grained Molecular Dynamics Simulations.

Journal of chemical information and modeling·2026
Same author

Visualizing the energy landscape for a molecular dynamics trajectory.

The Journal of chemical physics·2026
Same author

CD160-Derived Peptide as a Bidirectional Inhibitor Toward Immune Checkpoints BTLA/HVEM and HVEM/LIGHT.

Journal of medicinal chemistry·2025

Related Experiment Video

Updated: Jun 22, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.8K

Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT Interaction.

Piotr Ciura1, Pamela Smardz2, Marta Spodzieja1

  • 1Faculty of Chemistry, Fahrenheit Union of Universities in Gdańsk, University of Gdańsk, Baż̇yńskiego 8, 80-309 Gdansḱ, Poland.

The Journal of Physical Chemistry. B
|July 3, 2024
PubMed
Summary

Researchers designed peptide inhibitors targeting the herpesvirus entry mediator (HVEM)-LIGHT interaction to treat autoimmune diseases. Molecular dynamics simulations identified a potent peptide inhibitor, advancing therapeutic strategies for immune disorders.

More Related Videos

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.0K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Related Experiment Videos

Last Updated: Jun 22, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.8K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.0K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Area of Science:

  • Immunology and Molecular Biology
  • Computational Chemistry and Drug Design

Background:

  • The herpesvirus entry mediator (HVEM) and its ligand LIGHT are critical for immune regulation.
  • Dysregulated HVEM-LIGHT interactions contribute to chronic inflammation and autoimmune diseases.
  • Inhibiting HVEM-LIGHT offers therapeutic potential for autoimmune conditions and transplantation.

Purpose of the Study:

  • To design and identify peptide inhibitors targeting the HVEM-LIGHT interaction.
  • To elucidate the molecular mechanisms underlying HVEM-LIGHT binding.
  • To provide a foundation for developing novel peptide-based therapeutics for immune disorders.

Main Methods:

  • Extensive molecular dynamics (MD) simulations of 65 HVEM-derived peptides and 31 HVEM domain variants.
  • Microsecond-scale, all-atom MD simulations with MM-GBSA binding energy estimation.
  • Steered MD simulations and umbrella sampling to analyze binding energy profiles and mechanisms.
  • Circular dichroism spectroscopy to confirm structural properties.

Main Results:

  • Identified CRD2 domain variants of HVEM with high affinity for LIGHT.
  • A specific peptide variant (CRD2 domain with C58-C73 disulfide bond and K54E mutation) showed the highest binding affinity.
  • Confirmed the importance of the CRD2 domain and the Cys58-Cys73 disulfide bond in inhibiting HVEM-LIGHT interaction.
  • Revealed key interactions and distinct binding mechanisms for selected peptide variants.

Conclusions:

  • The study successfully designed potent peptide inhibitors for the HVEM-LIGHT interaction.
  • Provides critical insights into the molecular basis of HVEM-LIGHT interactions.
  • Establishes a systematic approach for peptide inhibitor design in drug development for immune-related disorders.